TYK2 Knockout Cell Line-293T

Human TYK2 Knockout Cell Line-HEK293T

Cat.No. : CSC-RT0451

Host Cell: HEK293T Target Gene: TYK2

Size: >1x10^6 cells/vial Validation: Sequencing

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Datasheet

Cat. No. CSC-RT0451
Cell Line Information This cell line is a stable cell line with a homozygous knockout of human TYK2 using CRISPR/Cas9.
Target Gene TYK2
Gene ID 7297
Genotype TYK2 (-/-)
Host Cell HEK293T
Cell Type Epithelial
Size >1x10^6 cells/vial
Sequencing Result Homozygous: 1 bp insertion in exon2
Species Homo sapiens (Human)
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Media Type Cells were cultured in DMEM supplemented with 10% fetal bovine serum.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6.
Freeze Medium Complete medium supplemented with 10% (v/v) DMSO
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations

The following safety precautions should be observed.

1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.

2. No eating, drinking or smoking while handling the stable line.

3. Wash hands after handling the stable line and before leaving the lab.

4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.

5. All waste should be considered hazardous.

6. Dispose of all liquid waste after each experiment and treat with bleach.

Ship Dry ice
Inquiry

Background

Case Study

Applications

TYK2 or tyrosine kinase 2 is an important enzyme that plays a key role in the signaling pathways of the immune system. TYK2 is essential for the proper functioning of various cytokine receptors, including interferons (IFNs), interleukins (ILs), and growth factor receptors. Specifically, it associates with receptors such as interferon-α/β receptor (IFNAR), interleukin-12 receptor (IL-12R), and interleukin-23 receptor (IL-23R). Through these associations, TYK2 regulates key biological processes such as cell proliferation, differentiation, apoptosis, and immune responses. This makes it a key mediator in both innate and adaptive immunity. Given its important role in immunity and cell signaling, dysregulated TYK2 activity has been implicated in a variety of diseases. Overactive TYK2 signaling may contribute to autoimmune diseases such as rheumatoid arthritis, lupus, and psoriasis, which result in excessive or misguided immune responses. Conversely, insufficient TYK2 activity can lead to immune deficiency, making individuals more susceptible to infection. The importance of TYK2 also extends to therapeutic potential. Researchers are actively exploring TYK2 inhibitors as potential treatments for autoimmune diseases and certain cancers. By specifically targeting TYK2 and modulating its activity, these therapies aim to restore balance to the immune system without broadly suppressing immune function, thereby reducing potential side effects.

Deciphering the complex dynamic events that control type I interferon (IFN) signaling is critical to uncovering key regulatory mechanisms in host antiviral defense. Here, researchers used TurboID-based proximity tagging combined with affinity purification mass spectrometry to comprehensively map the proximal human proteome of all seven canonical type I IFN signaling cascade members under basal and IFN-stimulated conditions. This revealed 103 high-confidence protein networks tightly associated with core members IFNAR1, IFNAR2, JAK1, TYK2, STAT1, STAT2, and IRF9, and validated several known constitutive protein assemblies, while also revealing novel stimulus-dependent and stimulus-independent associations between key signaling molecules. Mechanistically, PJA2 interacts with TYK2 and JAK1, promotes their non-degradative ubiquitination, and limits activating phosphorylation of TYK2, thereby inhibiting downstream STAT signaling. These high-resolution proximal protein maps provide global insights into the type I IFN signaling network and serve as a valuable resource for future exploration of its functional complexity.

TYK2 has been previously shown to stabilize IFNAR1 on the surface of unstimulated cells by preventing its internalization and turnover through endocytosis. In this study, the researchers used a HEK293T-based TYK2 KO cell line to confirm that the lack of TYK2 reduced the total level of IFNAR1 (Figure 1c). In addition, re-expression of TYK2 partially restored IFNAR1 protein levels, but further expression of PJA2-WT could not reverse this phenomenon (Figure 1c, d), indicating that PJA2-promoted TYK2 ubiquitination does not interfere with TYK2's ability to stabilize IFNAR1 levels.

Figure 1. c NE (non-edited) HEK293T cell clones or TYK2 KO (knockout) cell clones were transfected with the indicated plasmids, and total cell lysates were analyzed by SDS-PAGE and immunoblotting. d Quantification of IFNAR1 protein expression normalized to β-actin protein expression and made relative to one NE control clone in replicates of panel (c).Figure 1. c NE (non-edited) HEK293T cell clones or TYK2 KO (knockout) cell clones were transfected with the indicated plasmids, and total cell lysates were analyzed by SDS-PAGE and immunoblotting. d Quantification of IFNAR1 protein expression normalized to β-actin protein expression and made relative to one NE control clone in replicates of panel (c). (Schiefer, Samira, and Benjamin G. Hale. 2024)

The 293T human embryonic kidney cell-based TYK2 (tyrosine kinase 2) knockout cell line provides a versatile tool for studying a variety of biological processes and disease mechanisms. Here are some important applications: Drug screening: The TYK2 knockout cell line 293T can be an important tool for high-throughput drug screening. By eliminating the TYK2 kinase, researchers can identify compounds that selectively inhibit or reactivate pathways that depend on this enzyme. This is particularly valuable for developing targeted therapies for autoimmune diseases and certain cancers that are associated with TYK2. Functional studies: This cell line can be used to perform in-depth functional studies of the TYK2 protein. By comparing TYK2 knockout 293T cells to wild-type, researchers can reveal the specific role of TYK2 in various signaling pathways, including its involvement in cytokine signaling and immune responses. Pathway analysis: The TYK2 knockout 293T cell line provides a simplified model for studying downstream effectors and pathways activated by TYK2. This helps map the complete signaling cascade and understand the broader impact of TYK2 interactions and functions on cellular processes. Genetic interaction studies: Using TYK2 knockout 293T cells, scientists can study genetic interactions and compensation of other kinases or proteins.

For research use only. Not intended for any clinical use.
CBpromise   

Our promise to you:
Guaranteed product quality, expert customer support.

24x7 CUSTOMER SERVICE
CONTACT US TO ORDER

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

Accept Cookies
x